Stay updated with breaking news from Chromadex Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ChromaDex Co. (NASDAQ:CDXC – Get Free Report) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $1.66 and traded as high as $3.95. ChromaDex shares last traded at $3.95, with a volume of 346,416 shares traded. Analyst Upgrades and Downgrades […]
Through CERP™, over 275 global research agreements with 235+ independent, expert investigators are uncovering the full potential of NAD+ by researching ChromaDex’s Niagen® ingredient,... | June 16, 2023
ChromaDex Co. (NASDAQ:CDXC – Get Rating) Director Frank L. Jaksch, Jr. acquired 7,000 shares of the business’s stock in a transaction dated Monday, June 12th. The stock was purchased at an average cost of $1.69 per share, with a total value of $11,830.00. Following the transaction, the director now owns 231,339 shares of the company’s […]
ChromaDex Co. (NASDAQ:CDXC – Get Rating) – Stock analysts at HC Wainwright cut their Q2 2023 earnings per share estimates for ChromaDex in a research report issued to clients and investors on Monday, June 5th. HC Wainwright analyst R. Selvaraju now anticipates that the company will earn ($0.05) per share for the quarter, down from […]
ChromaDex Co. (NASDAQ:CDXC – Get Rating) Director Steven D. Rubin bought 7,000 shares of the business’s stock in a transaction that occurred on Thursday, May 25th. The shares were acquired at an average price of $1.46 per share, with a total value of $10,220.00. Following the transaction, the director now directly owns 7,000 shares of […]